HC Wainwright & Co. Reiterates Buy on AnaptysBio, Maintains $55 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Emily Bodnar has reiterated a Buy rating on AnaptysBio (NASDAQ:ANAB) and maintained a price target of $55.
August 14, 2024 | 6:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Emily Bodnar has reiterated a Buy rating on AnaptysBio and maintained a price target of $55.
The reiteration of a Buy rating and the maintenance of a $55 price target by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100